Exagen Inc. XGN Deferred Tax Assets, Operating Loss Carryforwards
Deferred Tax Assets, Operating Loss Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s deferred tax assets, operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s deferred tax assets, operating loss carryforwards?
- Exagen Inc. (XGN) reported deferred tax assets, operating loss carryforwards of $39.78M in Q4 2025.
- How has Exagen Inc.'s deferred tax assets, operating loss carryforwards changed year-over-year?
- Exagen Inc.'s deferred tax assets, operating loss carryforwards increased by 12.5% year-over-year, from $35.35M to $39.78M.
- What is the long-term trend for Exagen Inc.'s deferred tax assets, operating loss carryforwards?
- Over 5 years (2020 to 2025), Exagen Inc.'s deferred tax assets, operating loss carryforwards has grown at a 17.5% compound annual growth rate (CAGR), from $17.73M to $39.78M.